JosephMuenzerMD
Pediatrics • Chapel Hill, NCPediatric Endocrinology
Professor, Pediatrics, University of North Carolina at Chapel Hill School of Medicine
Dr. Muenzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
CB # 7487
University of North Carolina at Chapel Hill
Chapel Hill, NC 27599Phone+1 919-966-4202Fax+1 919-966-3025- Is this information wrong?
Education & Training
National Institutes of Health Clinical Center/Eunice Kennedy Shriver NICHDFellowship, Pediatric Endocrinology, 1982 - 1985
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1979 - 1982
Case Western Reserve University School of MedicineClass of 1979
Certifications & Licensure
NC State Medical License 1993 - 2024
MI State Medical License 1986 - 2002
WI State Medical License 1980 - 1999
MD State Medical License 1983 - 1985- American Board of Medical Genetics and Genomics Clinical Biochemical/Molecular Genetics
- American Board of Pediatrics Pediatrics
Clinical Trials
- Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase Start of enrollment: 2004 Sep 13
- A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Start of enrollment: 2009 Nov 18
- Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase® Start of enrollment: 2009 Jul 02
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNeurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.Joseph Muenzer, Barbara K Burton, Hernan M Amartino, Paul R Harmatz, Luis González Gutiérrez-Solana, Matilde Ruiz-Garcia, Yuna Wu, David Merberg, David Alexanderian, S...> ;Orphanet Journal of Rare Diseases. 2023 Nov 16
- Corrigendum to: Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study.Joseph Muenzer, Barbara K Burton, Paul Harmatz, Luis González Gutiérrez-Solana, Matilde Ruiz-Garcia, Simon A Jones, Nathalie Guffon, Michal Inbar-Feigenberg, Drago Bra...> ;Molecular Genetics and Metabolism. 2023 Nov 1
- Corrigendum to "Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II".Joseph Muenzer, Barbara K Burton, Paul Harmatz, Luis González Gutiérrez-Solana, Matilde Ruiz-Garcia, Simon A Jones, Nathalie Guffon, Michal Inbar-Feigenberg, Drago Bra...> ;Molecular Genetics and Metabolism. 2023 Nov 1
- Join now to see all
Press Mentions
Family of NC 5-Year-Old with Rare Disease Searching for Hope After Drug Trial EndsMay 11th, 2021- Applied Therapeutics to Host Virtual Rare Disease ForumMarch 16th, 2021
Sangamo Shares Plunge After Interim Results for MPS Candidates Fall Short of Clinical BenefitFebruary 8th, 2019- Join now to see all
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
